SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    In a new study led by Johns Hopkins Medicine, the experimental drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis), which is often incurable. Researchers say this study moves them closer to clinical trials for RK-33.

    LEARN MORE
    SEE ALL NEWS
    Recent Posts
    First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma Treatment Resistance in Prostate Cancer Elaine’s Story: A Journey of Strength, Faith, and Healing at Johns Hopkins In Extensive Sequencing Study, Scientists Find Few Links Between Cancer and Microbiome Johns Hopkins Investigators Create New Urine-based Test to ID Prostate Cancers New therapy kickstarts immune response to cancer Prostate Cancer Treatment: What to Do When It Stops Working 5 Healthy Habits That Help During Cancer Treatment Understanding Mammogram Results
    Johns Hopkins

    2026 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top